X0306 4 2022-02-25 0 0001420800 Colfax CORP CFX 0001205249 PRYOR DANIEL A 2711 CENTERVILLE ROAD SUITE 400 WILMINGTON DE 19808 0 1 0 0 EVP, Strategy & Business Dev. Common stock, par value $.001 2022-02-25 4 S 0 2024 42.18 D 172091 D Common stock, par value $.001 2022-02-25 4 A 0 62821 0.00 A 234912 D Common stock, par value $.001 2022-02-28 4 S 0 31274 41.181 D 203638 D Common stock, par value $.001 2312 I By 401K Plan Common stock, par value $.001 1000 I By trust for daughter Common stock, par value $.001 1000 I By trust for daughter Common stock, par value $.001 1000 I By trust for son The sales reported in this Form 4 were effected to meet tax obligations relating to the vesting and delivery of certain restricted stock units and performance-based restricted stock units ("PRSUs"). Reflects the certification of the performance criteria for PRSUs previously awarded in 2019. For more details on the PRSUs, please refer to the "Outstanding Equity Awards at 2020 Fiscal Year-End" table on page 42 of Colfax Corporation's 2021 Proxy Statement as filed with the Securities and Exchange Commission on April 1, 2021. /s/ Bradley Tandy, Attorney-in-Fact 2022-03-01